EFTA00956529Set 9
2013-03-147p5,347w
opportunity in HCV.
Ram Setvara)u More > Companies like Vertex Pharmaceuticals Inc. (VRTX:NASDA0). Pharmasset (acquired by Gilead
Sciences Inc. (GILD:NASDAO) in January 2012). Achillion Pharmaceuticals Inc.
(ACHN:NASDAO ... realaing and enhancing a return on its
"CUR had a S11B acquisition of Pharmasset. It will do this is by making sure its oral. pan-genotypic nucleoside
01011011101tai year ... sofosbuvir (formerly GS-7977), which it got in the Pharmasset deal. not only does well in Japan but also
2012.- (2/1O13)Neurals that it doesn't spit the profits with
https://www.justice.gov/epstein/files/DataSet%209/EFTA00956529.pdf